Adjuvant Nivolumab in High-Risk Muscle-Invasive Urothelial Carcinoma: Expanded Efficacy From CheckMate 274.

Bibliographic Details
Title: Adjuvant Nivolumab in High-Risk Muscle-Invasive Urothelial Carcinoma: Expanded Efficacy From CheckMate 274.
Authors: Galsky, Matthew D., Witjes, Johannes Alfred, Gschwend, Jürgen E., Milowsky, Matthew I., Schenker, Michael, Valderrama, Begoña P., Tomita, Yoshihiko, Bamias, Aristotelis, Lebret, Thierry, Shariat, Shahrokh F., Park, Se Hoon, Agerbaek, Mads, Jha, Gautam, Stenner, Frank, Ye, Dingwei, Giudici, Fabio, Dutta, Santanu, Askelson, Margarita, Nasroulah, Federico, Zhang, Joshua
Source: Journal of Clinical Oncology; 1/1/2025, Vol. 43 Issue 1, p15-21, 9p
Database: Supplemental Index
More Details
ISSN:0732183X
DOI:10.1200/JCO.24.00340
Published in:Journal of Clinical Oncology
Language:English